Latest Articles
Marisa And The Moths release new music video for ‘Nothing’s Getting Better’ - Distorted Sound Magazine -
Marisa And The Moths release new music video for ‘Nothing’s Getting Better’ Distorted Sound Magazine -
Published: April 19, 2026, 7:45 p.m.
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily
Published: April 18, 2026, 6:23 p.m.
State approves $4M for county jails, Penobscot County officials say permanent increase needed - newscentermaine.com
State approves $4M for county jails, Penobscot County officials say permanent increase needed newscentermaine.com
Published: April 17, 2026, 12:08 p.m.
Pingree calls for release of Portland woman held in ICE custody since November - newscentermaine.com
Pingree calls for release of Portland woman held in ICE custody since November newscentermaine.com
Published: April 17, 2026, 12:06 p.m.
Medicus Pharma to Present Phase 1 Teverelix Data at Endocrinology Meeting - MyChesCo
Medicus Pharma to Present Phase 1 Teverelix Data at Endocrinology Meeting MyChesCo
Published: April 17, 2026, 6 a.m.
Priyadarshan Releases Horror Comedy Bhooth Bangla in Cinemas - world.infonasional.com
Priyadarshan Releases Horror Comedy Bhooth Bangla in Cinemas world.infonasional.com
Published: April 17, 2026, 5:22 a.m.
Absci Highlights AI Antibody Platform, Teases ABS-201 Hair-Loss Data and 2026 Milestones at Needham Conference - MarketBeat
Absci Highlights AI Antibody Platform, Teases ABS-201 Hair-Loss Data and 2026 Milestones at Needham Conference MarketBeat
Published: April 16, 2026, 7:09 p.m.
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy - TipRanks
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy TipRanks
Published: April 15, 2026, 1:38 p.m.
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer - MedPage Today
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer MedPage Today
Published: April 13, 2026, 3:43 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
Link copied to clipboard!